Overview

Safety and Efficacy Study of DAV132 in Healthy Volunteers

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether DAV132 is safe and effective for capturing fecal residues of moxifloxacin in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Da Volterra
Treatments:
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination